共 50 条
- [21] Randomized phase III study of S-1 plus oxaliplatin versus S-1 plus cisplatin for first-line treatment of advanced gastric cancerJOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)Higuchi, KatsuhikoKoizumi, WasaburoYamada, YasuhideNishikawa, KazuhiroGotoh, MasahiroFuse, NozomuSugimoto, NaotoshiNishina, TomohiroAmagai, KenjiChin, KeishoNiwa, YasumasaNegoro, YujiImamura, HiroshiTsuda, MasahiroYasui, HirotumiFujii, HirofumiYamaguchi, KenseiYasui, HisateruHamada, ChikumaHyodo, Ichinosuke
- [22] Biweekly Docetaxel and S-1 Combination Chemotherapy as First-line Treatment for Elderly Patients with Advanced Gastric CancerANTICANCER RESEARCH, 2013, 33 (02) : 697 - 704Kunisaki, ChikaraTakahashi, MasazumiOno, Hidetaka A.Hasegawa, ShinichiTsuchida, KazuhitoOshima, TakashiOta, MitsuyoshiFukushima, TadaoTokuhisa, MotohikoIzumisawa, YusuiceTakagawa, RyoKimura, JunKosaka, TakashiMakino, HirochikaAkiyama, HirotoshiEndo, Itaru
- [23] A phase II study of S-1 and irinotecan combination chemotherapy in patients with advanced gastric cancer as a first-line therapyEJC SUPPLEMENTS, 2007, 5 (04): : 274 - 274Ryoo, B. Y.Kang, H. J.Yang, S. H.Cho, S. H.Oh, S. J.Lee, M. H.Song, E. K.Chung, H. C.
- [24] Phase II clinical trial of S-1 plus nanoparticle albumin-bound paclitaxel as first-line chemotherapy for patients with metastatic gastric cancerJOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)Xu, Rui-huaHe, Ming-mingZhang, Dong-shengWang, FengJin, Ying
- [25] S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: updated results from a phase 3 trialBMC Cancer, 14Seung Tae KimYong Sang HongHo Yeong LimJeeyun LeeTae Won KimKyu-Pyo KimSun Young KimJi Yeon BaekJee Hyun KimKeun-Wook LeeIk-Joo ChungSang-Hee ChoKyung Hee LeeSang Joon ShinHye Jin KangDong Bok ShinJae Won LeeSook Jung JoYoung Suk Park
- [26] S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: updated results from a phase 3 trialBMC CANCER, 2014, 14Kim, Seung TaeHong, Yong SangLim, Ho YeongLee, JeeyunKim, Tae WonKim, Kyu-PyoKim, Sun YoungBaek, Ji YeonKim, Jee HyunLee, Keun-WookChung, Ik-JooCho, Sang-HeeLee, Kyung HeeShin, Sang JoonKang, Hye JinShin, Dong BokLee, Jae WonJo, Sook JungPark, Young Suk
- [27] Cisplatin and capecitabine with and without docetaxel as a first-line chemotherapy in patients with metastatic gastric carcinoma: Single clinical experience.JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)Narimanov, MekhtyTryakin, AlexeyZarkua, VarlamBazin, IgorGarin, AugustTjulandin, Sergei
- [28] Phase II study of a triplet regimen of S-1 combined with irinotecan and oxaliplatin in patients with metastatic gastric cancer: clinical and pharmacogenetic resultsANNALS OF ONCOLOGY, 2011, 22 (04) : 890 - 896Park, S. R.Kong, S. -Y.Rhee, J.Park, Y. -I.Ryu, K. W.Lee, J. H.Kim, Y. -W.Choi, I. J.Kim, C. G.Lee, J. Y.Cho, S. -J.Kim, N. K.
- [29] FIRST-LINE SINGLE AGENT CHEMOTHERAPY IN RECURRED OR METASTATIC GASTRIC CANCER PATIENTS WITH POOR CLINICAL CONDITIONANNALS OF ONCOLOGY, 2012, 23 : 48 - 48Hwang, Jun-EulKim, Dae-EunShim, Hyun-JeongBae, Woo-KyunCho, Sang-HeeChung, Ik-Joo
- [30] First-line chemotherapy with S-1 alone or S-1 plus cisplatin for elderly patients with advanced gastric cancer: a multicenter propensity score matched studyGastric Cancer, 2018, 21 : 792 - 801Akitaka MakiyamaKenji KuniedaMasaaki NoguchiTakeshi KajiwaraTakao TamuraKoji TakedaJunko SugiyamaKeiko MinashiToshikazu MoriwakiNaotoshi SugimotoMichitaka NagaseYuji NegoroTakashi TsudaHideki ShimodairaNaohiro OkanoAkihito TsujiDaisuke SakaiKazuhiro YanagiharaShinya UedaShingo TamuraSatoshi OtsuTakuya HondaYuzo MatsushitaTatsuya OkunoTomomi KashiwadaAkira NozakiMasahide EbiHiroyuki OkudaMototsugu ShimokawaShuichi HironakaIchinosuke HyodoEishi BabaNarikazu BokuKei MuroTaito Esaki